HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
12 hedge funds and large institutions have $741K invested in Hepion Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
Holders
12
Holding in Top 10
–
Calls
$142K
Puts
$184K
Top Buyers
| 1 | +$178K | |
| 2 | +$103K | |
| 3 | +$63K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$49K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$48K |